Borre Robertsen

Title: Borre Robertsen – Innovator in Glucan Treatments

Introduction

Borre Robertsen, an innovative inventor based in Tromsø, Norway, has made significant contributions to the field of glucan treatments. With an impressive portfolio of three patents, Robertsen is recognized for his groundbreaking work in enhancing animal immune systems through the use of novel glucan products derived from yeast cells.

Latest Patents

Robertsen's latest patents include two related innovations focused on enzyme treatment of glucans. The first patent describes the use of β-(1-6)-Glucanase treatment of glucan extracted from yeast cells, which can be of either pure or feed grade. This innovative approach results in a new glucan product that plays a vital role in stimulating the immune responses of host animals. The solubilization of yeast cell glucan is a noteworthy advancement that further expands its usefulness as an adjuvant in immunostimulation.

Career Highlights

Throughout his career, Borre Robertsen has worked with esteemed organizations, including Biotec Pharmacon Asa. His efforts in the field of biotechnology and immunology have positioned him as a leader in developing glucan-based solutions for enhancing animal health.

Collaborations

Robertsen has collaborated with notable colleagues such as Rolf Einar Engstad and Finn Kortner. Their joint efforts have contributed to advancing research in glucan treatments, paving the way for innovative applications in the industry.

Conclusion

Borre Robertsen stands out as a prominent inventor in the realm of glucan treatments, with patents that significantly enhance the understanding of immune system stimulation in animals. His contributions reflect a commitment to innovation and improvement in animal health through cutting-edge research and collaboration. The impact of his work continues to resonate within the scientific community, inspiring further advancements in the field.